Cargando…
Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire
BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire....
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667576/ https://www.ncbi.nlm.nih.gov/pubmed/36405523 http://dx.doi.org/10.4081/jphia.2022.1748 |
_version_ | 1784831751306084352 |
---|---|
author | Usui, Rui Kanamori, Shogo Aomori, Maki Watabe, Setsuko |
author_facet | Usui, Rui Kanamori, Shogo Aomori, Maki Watabe, Setsuko |
author_sort | Usui, Rui |
collection | PubMed |
description | BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. METHODS: Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports. RESULTS: Among 67 patients studied, the biggest age group was 60-69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity. CONCLUSIONS: To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed. |
format | Online Article Text |
id | pubmed-9667576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | PAGEPress Publications, Pavia, Italy |
record_format | MEDLINE/PubMed |
spelling | pubmed-96675762022-11-17 Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire Usui, Rui Kanamori, Shogo Aomori, Maki Watabe, Setsuko J Public Health Afr Brief Reports BACKGROUND: Although COVID-19 has spread in Côte d’Ivoire, there is no report that summarizes the comorbidities of COVID-19 death cases. OBJECTIVE: To verify the types and prevalence of commodities associated with recorded COVID-19 deaths compared with the general adult population in Côte d’Ivoire. METHODS: Data on the comorbidities of COVID-19 deaths and the country’s disease structure were collected from official government reports and WHO’s reports. RESULTS: Among 67 patients studied, the biggest age group was 60-69 years old with 23 people (34%). Fifty-four patients (81%) had non-communicable diseases (NCDs) as comorbidities. The prevalence ratio between COVID-19 deaths and general adult population was 8.96 [95% Confidence Interval: 6.86-11.68] for diabetes, 1.74 [1.27-2.37] for hypertension, and 2.16 [1.32-3.51] for obesity. CONCLUSIONS: To reduce the risk of death from COVID-19 in Côte d’Ivoire, focused infection prevention measures for elderly and diabetic patients are needed. PAGEPress Publications, Pavia, Italy 2022-10-25 /pmc/articles/PMC9667576/ /pubmed/36405523 http://dx.doi.org/10.4081/jphia.2022.1748 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Brief Reports Usui, Rui Kanamori, Shogo Aomori, Maki Watabe, Setsuko Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire |
title | Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire |
title_full | Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire |
title_fullStr | Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire |
title_full_unstemmed | Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire |
title_short | Analysis of COVID-19 mortality in patients with comorbidities in Côte d’Ivoire |
title_sort | analysis of covid-19 mortality in patients with comorbidities in côte d’ivoire |
topic | Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667576/ https://www.ncbi.nlm.nih.gov/pubmed/36405523 http://dx.doi.org/10.4081/jphia.2022.1748 |
work_keys_str_mv | AT usuirui analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire AT kanamorishogo analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire AT aomorimaki analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire AT watabesetsuko analysisofcovid19mortalityinpatientswithcomorbiditiesincotedivoire |